Cargando…
The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic
BACKGROUND: Presymptomatic COVID-19 patients have been identified as a major stumbling block in efforts to break the chain of transmission. Studies on temporal dynamics of its shedding suggests it peaks 1–2 days prior to any symptom onset. Therefore, a large proportion of patients are actively sprea...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942693/ https://www.ncbi.nlm.nih.gov/pubmed/33750347 http://dx.doi.org/10.1186/s12879-021-05849-7 |
_version_ | 1783662365953228800 |
---|---|
author | Tan, Juen Kiem Leong, Dalleen Munusamy, Hemalatha Zenol Ariffin, Nor Hazwani Kori, Najma Hod, Rozita Periyasamy, Petrick |
author_facet | Tan, Juen Kiem Leong, Dalleen Munusamy, Hemalatha Zenol Ariffin, Nor Hazwani Kori, Najma Hod, Rozita Periyasamy, Petrick |
author_sort | Tan, Juen Kiem |
collection | PubMed |
description | BACKGROUND: Presymptomatic COVID-19 patients have been identified as a major stumbling block in efforts to break the chain of transmission. Studies on temporal dynamics of its shedding suggests it peaks 1–2 days prior to any symptom onset. Therefore, a large proportion of patients are actively spreading the disease unknowingly whilst undetected. However, lengthy lockdowns and isolation leads to a host of socioeconomic issues and are impractical. Conversely, there exists no study describing this group and their clinical significance despite their key role in disease transmission. METHODS: As a result, we devised a retrospective study to look at the prevalence of presymptomatic patients with COVID-19 from data sourced via our medical records office. Subsequently, we identify early indicators of infection through demographic information, biochemical and radiological abnormalities which would allow early diagnosis and isolation. In addition, we will look into the clinical significance of this group and their outcome; if it differs from asymptomatic or symptomatic patients. Descriptive statistics were used in addition to tabulating the variables and corresponding values for reference. Variables are compared between the presymptomatic group and others via Chi-square testing and Fisher’s exact test, accepting a p value of < 0.05 as significant. RESULTS: Our analysis shows a higher proportion of presymptomatic patients with atypical symptoms like chest pain while symptomatic patients commonly present with respiratory symptoms like cough and shortness of breath. Besides that, there were more females presenting as presymptomatic patients compared to males (p = 0.019) and these group of patients were likely to receive treatment (p < 0.001). Otherwise, we were not able to identify other statistically significant markers suggesting a patient is presymptomatic. CONCLUSION: As we have little means of identifying these silent spreaders, it highlights further the importance of general measures implemented to stop COVID-19 transmission like social distancing, face mask, and widespread testing. |
format | Online Article Text |
id | pubmed-7942693 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-79426932021-03-10 The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic Tan, Juen Kiem Leong, Dalleen Munusamy, Hemalatha Zenol Ariffin, Nor Hazwani Kori, Najma Hod, Rozita Periyasamy, Petrick BMC Infect Dis Research Article BACKGROUND: Presymptomatic COVID-19 patients have been identified as a major stumbling block in efforts to break the chain of transmission. Studies on temporal dynamics of its shedding suggests it peaks 1–2 days prior to any symptom onset. Therefore, a large proportion of patients are actively spreading the disease unknowingly whilst undetected. However, lengthy lockdowns and isolation leads to a host of socioeconomic issues and are impractical. Conversely, there exists no study describing this group and their clinical significance despite their key role in disease transmission. METHODS: As a result, we devised a retrospective study to look at the prevalence of presymptomatic patients with COVID-19 from data sourced via our medical records office. Subsequently, we identify early indicators of infection through demographic information, biochemical and radiological abnormalities which would allow early diagnosis and isolation. In addition, we will look into the clinical significance of this group and their outcome; if it differs from asymptomatic or symptomatic patients. Descriptive statistics were used in addition to tabulating the variables and corresponding values for reference. Variables are compared between the presymptomatic group and others via Chi-square testing and Fisher’s exact test, accepting a p value of < 0.05 as significant. RESULTS: Our analysis shows a higher proportion of presymptomatic patients with atypical symptoms like chest pain while symptomatic patients commonly present with respiratory symptoms like cough and shortness of breath. Besides that, there were more females presenting as presymptomatic patients compared to males (p = 0.019) and these group of patients were likely to receive treatment (p < 0.001). Otherwise, we were not able to identify other statistically significant markers suggesting a patient is presymptomatic. CONCLUSION: As we have little means of identifying these silent spreaders, it highlights further the importance of general measures implemented to stop COVID-19 transmission like social distancing, face mask, and widespread testing. BioMed Central 2021-03-09 /pmc/articles/PMC7942693/ /pubmed/33750347 http://dx.doi.org/10.1186/s12879-021-05849-7 Text en © The Author(s) 2021 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Article Tan, Juen Kiem Leong, Dalleen Munusamy, Hemalatha Zenol Ariffin, Nor Hazwani Kori, Najma Hod, Rozita Periyasamy, Petrick The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
title | The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
title_full | The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
title_fullStr | The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
title_full_unstemmed | The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
title_short | The prevalence and clinical significance of Presymptomatic COVID-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
title_sort | prevalence and clinical significance of presymptomatic covid-19 patients: how we can be one step ahead in mitigating a deadly pandemic |
topic | Research Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7942693/ https://www.ncbi.nlm.nih.gov/pubmed/33750347 http://dx.doi.org/10.1186/s12879-021-05849-7 |
work_keys_str_mv | AT tanjuenkiem theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT leongdalleen theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT munusamyhemalatha theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT zenolariffinnorhazwani theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT korinajma theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT hodrozita theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT periyasamypetrick theprevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT tanjuenkiem prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT leongdalleen prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT munusamyhemalatha prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT zenolariffinnorhazwani prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT korinajma prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT hodrozita prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic AT periyasamypetrick prevalenceandclinicalsignificanceofpresymptomaticcovid19patientshowwecanbeonestepaheadinmitigatingadeadlypandemic |